Ubiquitylation of CD98 limits cell proliferation and clonal expansion

Journal of Cell Science

Volumn 128, Issue 23, 2015, Pages 4273-4278

  Ablack, Jailal N G ^a   Metz, Patrick J ^a   Chang, John T ^a   Cantor, Joseph M ^a   Ginsberg, Mark H ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

CD98; Clonal expansion; Immunobiology; Integrin signaling

Indexed keywords

CD98 ANTIGEN; MARCH1 PROTEIN; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; MARCH1 PROTEIN, HUMAN; MARCH1 PROTEIN, MOUSE; MARCH8 PROTEIN, HUMAN; MARCH8 PROTEIN, MOUSE; SLC3A2 PROTEIN, HUMAN; SLC3A2 PROTEIN, MOUSE; UBIQUITIN PROTEIN LIGASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CELL PROLIFERATION; CLONING; DOWN REGULATION; HELA CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; UBIQUITINATION; ANIMAL; GENETICS; JURKAT CELL LINE; LYSOSOME; METABOLISM; PHYSIOLOGY; PROTEIN DEGRADATION;

ANIMALS; ANTIGENS, CD98 HEAVY CHAIN; CELL PROLIFERATION; HELA CELLS; HUMANS; JURKAT CELLS; LYSOSOMES; MICE; PROTEOLYSIS; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 84949100701     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.178129     Document Type: Article

References (32)

1. Baravalle, G., Park, H., McSweeney, M., Ohmura-Hoshino, M., Matsuki, Y., Ishido, S. and Shin, J.-S. (2011). Ubiquitination of CD86 is a key mechanism in regulating antigen presentation by dendritic cells. J. Immunol. 187, 2966-2973.
2. Bartee, E., Mansouri, M., Hovey Nerenberg, B. T., Gouveia, K. and Fruh, K. (2004). Downregulation of major histocompatibility complex class I by human ubiquitin ligases related to viral immune evasion proteins. J. Virol. 78, 1109.
3. Beacock-Sharp, H., Donachie, A. M., Robson, N. C. and Mowat, A. M. (2003). A role for dendritic cells in the priming of antigen-specific CD4+ and CD8+ T lymphocytes by immune-stimulating complexes in vivo. Int. Immunol. 15, 711-720.
4. Boehm, T. (2011). Design principles of adaptive immune systems. Nat. Rev. Immunol. 11, 307-317.
5. Cantor, J. M. and Ginsberg, M. H. (2012). CD98 at the crossroads of adaptive immunity and cancer. J. Cell Sci. 125, 1373-1382.
6. Cantor, J., Browne, C. D., Ruppert, R., Féral, C. C., Fässler, R., Rickert, R. C. and Ginsberg, M. H. (2009). CD98hc facilitates B cell proliferation and adaptive humoral immunity. Nat. Immunol. 10, 412-419.
7. Cantor, J., Slepak, M., Ege, N., Chang, J. T. and Ginsberg, M. H. (2011). Loss of T cell CD98 H chain specifically ablates T cell clonal expansion and protects from autoimmunity. J. Immunol. 187, 851-860.
8. Estrach, S., Lee, S.-A., Boulter, E., Pisano, S., Errante, A., Tissot, F. S., Cailleteau, L., Pons, C., Ginsberg, M. and Feral, C. C. (2014). CD98hc (SLC3A2) loss protects against Ras-driven tumorigenesis by modulating integrin-mediated mechanotransduction. Cancer Res. 74, 6878-6889.
9. Eyster, C. A, Cole, N. B., Petersen, S., Viswanathan, K., Früh, K. and Donaldson, J. G. (2011). MARCH ubiquitin ligases alter the itinerary of clathrin-independent cargo from recycling to degradation. Mol. Biol. Cell 22, 3218-3230.
10. Feral, C. C., Nishiya, N., Fenczik, C. A., Stuhlmann, H., Slepak, M. and Ginsberg, M. H. (2005). CD98hc (SLC3A2) mediates integrin signaling. Proc. Natl. Acad. Sci. USA 102, 355-360.
11. Fogelstrand, P., Feral, C. C., Zargham, R. and Ginsberg, M. H. (2009). Dependence of proliferative vascular smooth muscle cells on CD98hc (4F2hc, SLC3A2). J. Exp. Med. 206, 2397-2406.
12. Fujita, H., Iwabu, Y., Tokunaga, K. and Tanaka, Y. (2013). Membrane-associated RING-CH (MARCH) 8 mediates the ubiquitination and lysosomal degradation of the transferrin receptor. J. Cell Sci. 126, 2798-2809.
13. Gottesdiener, K. M., Karpinski, B. A., Lindsten, T., Strominger, J. L., Jones, N. H., Thompson, C. B. and Leiden, J. M. (1988). Isolation and structural characterization of the human 4F2 heavy-chain gene, an inducible gene involved in T-lymphocyte activation. Mol. Cell. Biol. 8, 3809-3819.
14. Hayes, G. M., Chinn, L., Cantor, J. M., Cairns, B., Levashova, Z., Tran, H., Velilla, T., Duey, D., Lippincott, J., Zachwieja, J. et al. (2015). Antitumor activity of an anti-CD98 antibody. Int. J. Cancer 137, 710-720.
15. Haynes, B. F., Hemler, M. E., Mann, D. L., Eisenbarth, G. S., Shelhamer, J., Mostowski, H. S., Thomas, C. A., Strominger, J. L. and Fauci, A. S. (1981). Characterization of a monoclonal antibody (4F2) that binds to human monocytes and to a subset of activated lymphocytes. J. Immunol. 126, 1409-1414.
16. Henderson, N. C., Collis, E. A., Mackinnon, A. C., Simpson, K. J., Haslett, C., Zent, R., Ginsberg, M. and Sethi, T. (2004). CD98hc (SLC3A2) interaction with beta 1 integrins is required for transformation. J. Biol. Chem. 279, 54731-54741.
17. Holte, H., Davies, C. D. L., Kvaløy, S., Smeland, E. B., Foss-Abrahamsen, A., Kaalhus, O., Marton, P. F. and Godal, T. (1987). The activation-associated antigen 4f2 predicts patient survival in low-grade b-cell lymphomas. Int. J. Cancer 39, 590-594.
18. Holte, H., De Lange Davies, C., Beiske, K., Stokxe, T., Marton, P. F., Smeland, E. B., Høie, J. and Kvaløy, S. (1989). Ki67 and 4F2 antigen expression as well as dna synthesis predict survival at relapse/tumour progression in low-grade B-cell lymphoma. Int. J. Cancer 44, 975-980.
19. Hommel, M. and Kyewski, B. (2003). Dynamic changes during the immune response in T cell-antigen-presenting cell clusters isolated from lymph nodes. J. Exp. Med. 197, 269-280.
20. Karpinski, B. A, Yang, L. H., Cacheris, P., Morle, G. D. and Leiden, J. M. (1989). The first intron of the 4F2 heavy-chain gene contains a transcriptional enhancer element that binds multiple nuclear proteins. Mol. Cell. Biol. 9, 2588-2597.
21. Li, O., Chang, X., Zhang, H., Kocak, E., Ding, C., Zheng, P. and Liu, Y. (2006). Massive and destructive T cell response to homeostatic cue in CD24-deficient lymphopenic hosts. J. Exp. Med. 203, 1713-1720.
22. Lindsten, T., June, C. H., Thompson, C. B. and Leiden, J. M. (1988). Regulation of 4F2 heavy-chain gene expression during normal human T-cell activation can be mediated by multiple distinct molecular mechanisms. Mol. Cell. Biol. 8, 3820-3826.
23. Matsuki, Y., Ohmura-Hoshino, M., Goto, E., Aoki, M., Mito-Yoshida, M., Uematsu, M., Hasegawa, T., Koseki, H., Ohara, O., Nakayama, M. et al. (2007). Novel regulation of MHC class II function in B cells. EMBO J. 26, 846-854.
24. Nikolova, M., Guenova, M., Taskov, H., Dimitrova, E. and Staneva, M. (1998). Levels of expression of CAF7 (CD98) have prognostic significance in adult acute leukemia. Leuk. Res. 22, 39-47.
25. Oh, J., Wu, N., Baravalle, G., Cohn, B., Ma, J., Lo, B., Mellman, I., Ishido, S., Anderson, M. and Shin, J.-S. (2013). MARCH1-mediated MHCII ubiquitination promotes dendritic cell selection of natural regulatory T cells. J. Exp. Med. 210, 1069-1077.
26. Oh, H. S., Choi, B. K., Kim, Y. H., Lee, D. G., Hwang, S., Lee, M. J., Park, S. H., Bae, Y.-S. and Kwon, B. S. (2015). 4-1BB signaling enhances primary and secondary population expansion of CD8+ T cells by maximizing autocrine IL-2/IL-2 receptor signaling. PLoS ONE 10, e0126765.
27. Parish, C. R., Glidden, M. H., Quah, B. J. C. and Warren, H. S. (2001). Use of the intracellular fluorescent dye CFSE to monitor lymphocyte migration and proliferation. In Current Protocols in Immunology. John Wiley&Sons, Inc.
28. Salter, D. M., Krajewski, A. S., Sheehan, T., Turner, G., Cuthbert, R. J. and McLean, A. (1989). Prognostic significance of activation and differentiation antigen expression in B-cell non-Hodgkin's lymphoma. J. Pathol. 159, 211-220.
29. Sinclair, L. V., Rolf, J., Emslie, E., Shi, Y.-B., Taylor, P. M. and Cantrell, D. A. (2013). Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation. Nat. Immunol. 14, 500-508.
30. Sprent, J. and Surh, C. D. (2002). T cell memory. Annu. Rev. Immunol. 20, 551-579.
31. Teague, R. M., Tempero, R. M., Thomas, S., Murali-Krishna, K. and Nelson, B. H. (2004). Proliferation and differentiation of CD8+ T cells in the absence of IL-2/15 receptor beta-chain expression or STAT5 activation. J. Immunol. 173, 3131-3139.
32. Verrey, F., Closs, E. I., Wagner, C. A., Palacin, M., Endou, H. and Kanai, Y. (2004). CATs and HATs: the SLC7 family of amino acid transporters. Pflugers Arch. 447, 532-542.